Freenome, Inc. FRNM
$10.25
▼ -3.03%
($-0.32)
📅 Earnings This Week
Open
$10.49
Prev Close
$10.57
Day Range
$10.05 – $10.71
52W Range
$9.71 – $17.50
Market Cap
$1.14B
P/E (TTM)
1,356.12
Beta
0.75
EPS (TTM)
$-0.07
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-06-12 |
| Shares Out. | 107,450,000 |
| Website | freenome.com ↗ |
| Phone | 13026587581 |
About Freenome, Inc.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Freenome, Inc. is a publicly traded company under the ticker symbol FRNM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-11-01)